Newborn screening for metabolic disorders

Journal of Pediatrics

Volumn 148, Issue 5, 2006, Pages

  Marsden, Deborah ^a,b,c   Larson, Cecilia ^a,b,c   Levy, Harvey L ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; DNA SCREENING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; GALACTOSEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; META ANALYSIS; METABOLIC DISORDER; MORBIDITY; NEWBORN SCREENING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SYSTEMATIC REVIEW; TANDEM MASS SPECTROMETRY; TYROSINEMIA;

EID: 33646849262     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.12.021     Document Type: Article

References (71)

1. Guthrie R. The origin of newborn screening. Screening 1 (1992) 5-15
2. Koch J. Robert Guthrie. The PKU Story (1997), Hope Publishing House, Pasadena, Calif
3. Guthrie R., and Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32 (1963) 338-343
4. Fearing M.K., and Levy H.L. Expanded newborn screening using tandem mass spectrometry. Adv Pediatr 50 (2003) 81-111
5. Guthrie R. Screening for "inborn errors of metabolism" in the newborn infant. a multiple test program. Birth Def Orig Art Ser 4 (1968) 92-96
6. Beutler E., and Baluda M.C. A single spot screening test for galactosemia. J Lab Clin Med 68 (1966) 137-141
7. Dussault J.H., Coulombe P., Laberge C., Letarte J., Guyda H., and Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr 86 (1975) 670-674
8. Garrick M.D., Dembure P., and Guthrie R. Sickle-cell anemia and other hemglobinopathies. procedures and strategy for screening employing spots of blood on filter paper as specimens. N Engl J Med 288 (1973) 1265-1268
9. Pang S., Hotchkiss J., Drash A.L., Levine L.S., and New M.I. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay. its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 45 (1977) 1003-1008
10. Qu Y., Miller J.B., Slocum R.H., and Shapira E. Rapid automated quantitation of isoleucine, leucine, tyrosine and phenylalanine from dried blood filter paper specimens. Clin Chim Acta 203 (1991) 191-198
11. Levy H.L., and Albers S. Genetic screening of newborns. Annu Rev Genomics Hum Genet 1 (2000) 139-177
12. Levy H.L. Newborn screening by tandem mass spectrometry. a new era. Clin Chem 44 (1998) 2401-2402
13. Chace D.H., and Kalas T.A. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem 38 (2005) 296-309
14. Newborn Screening Task Force. Serving the family from birth to the medical home. Pediatrics 106 (2000) 383-427
15. Levy HL. Historical perspectives: newborns metabolic screening. Neoreviews 2005; 6:e57-60. Available online at: www.NeoReviews.org
16. Andrews L.B. State laws and regulations governing newborn screening (1985), American Bar Foundation, Chicago
17. Schulze A., Lindner M., Kohlmüller D., Olgemöller K., Mayatepek E., and Hoffmann G.F. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry. results, outcome, and implications. Pediatrics 111 (2003) 1399-1406
18. Chace D.H., Kalas T.A., and Naylor E.W. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet 3 (2002) 17-45
19. Holtzman C., Slazyk W.E., Cordero J.F., and Hannon W.H. Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism. Pediatrics 78 (1986) 553-558
20. Atkinson K., Zuckerman B., Sharfstein J.M., Levin D., Blatt R.J.R., and Koh H.K. A public health response to emerging technology. expansion of the Massachusetts newborn screening program. Pub Health Rep 116 (2000) 112-131
21. Comeau A.M., Larson C., and Eaton R. Integration of new genetic diseases into statewide newborn screening. New England experience. Am J Med Genet Part C (Semin Med Genet) 125C (2004) 35-41
22. Millington D.S., Kodo N., Norwood D.L., and Roe C.R. Tandem mass spectrometry. a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 13 (1990) 321-324
23. Andresen B.S., Dobrowolski S.F., O'Reilly L., Muenzer J., McCandless S.E., Frazier D.M., et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms. identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet 68 (2001) 1408-1418
24. National Newborn Screening and Genetic Resource Center, Austin, TX. Available online at: www.genes-r-us.org. Accessed December 12, 2005
25. Available online at: http://mchb.hrsa.gov/screening/
26. New England Consortium of Metabolic Programs. www.childrenshospital.org/newenglandconsortium
27. Zytkovicz T.H., Fitzgerald E.F., Marsden D., Larson C.A., Shih V.E., Johnson D.M., et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots. a two-year summary from the New England newborn screening program. Clin Chem 47 (2001) 11 1945-55
28. Wilcken B., Wiley V., Hammond J., and Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348 (2003) 2304-2312
29. Waisbren S.E., Albers S., Amato S., Ampola M., Brewster T.G., Demmer L., et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 290 (2003) 2564-2572
30. Ziadeh R., Hoffman E.P., Finegold D.N., Hoop R.C., Brackett J.C., Strauss A.W., et al. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania. neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 37 (1995) 675-678
31. Cederbaum D.S. SIDS and disorders of fatty acid oxidation. where do we go from here?. J Pediatr 132 (1998) 913-914
32. Wang S.S., Fernhoff P.M., and Khoury M.J. Is the G985A allelic variant of medium-chain acyl-CoA dehydrogenase a risk factor for sudden infant death syndrome?. A pooled analysis. Pediatrics 105 (2000) 1175-1176
33. Pollitt R.J., and Leonard J.V. Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child 79 (1998) 116-119
34. Carpenter K., Wiley V., Sim K.G., Heath D., and Wilcken B. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275,000 babies. Arch Dis Child Fetal Neonatal Ed 85 (2001) F0-F4
35. Chace D.H., DiPerna J.C., Mitchell B.L., Sgroi B., Hofman L.F., and Naylor E.W. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 47 (2001) 1166-1182
36. Spiekerkoetter U., Sun B., Zytkovicz T., Wanders R., Strauss A.W., and Wendel U. MS/MS-Based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency. J Pediatr 143 (2003) 335-342
37. Ensenauer R., Vockley J., Willard J.-M., Huey J.C., Sass J.O., Edland S.D., et al. A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75 (2004) 1136-1142
38. Rhead W.J., White A., Allain D., Lindh H., Hanson K., van Calcar S., et al. Very-long-chain acyl-CoA dehydrogenase (VLCAD), 2-methylbutyryl-AD (2-MBAD), short chain-AD (SCAD), and 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiencies. newborn screening detects clinically benign or very mild cases. Molec Genet Metab 81 (2004) 153-186
39. Losty H., Melville-Thomas G., Pollitt R., and Davies S. Medium chain acyl CoA deficiency sudden, unexpected death in a 23 year old woman. J Inherit Metab Dis 24 suppl 1 (2001) 68
40. Feillet F., Bollaert P.E., deChillou C., Lefebvre E., Vianey-Saban C., and Vidailhet M. First adult presentation of MCAD deficiency revealed by coma and sever arythmia. J Inherit Metab Dis 25 suppl 1 (2002) 68
41. Liebl B., Nennstiel-Ratzel U., Roscher A., and von Kries R. Data required for the evaluation of newborn screening programmes. Eur J Pediatr 162 (2003) S57-S61
42. Dezateux C. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency. evaluating the effects on outcome. Eur J Pediatr 162 (2003) S25-S28
43. Abdenur J.E., Chamoles N.A., Guinle A.E., Schenone A.B., and Fuertes A.N.J. Diagnosis of isovaleric acidaemia by tandem mass spectrometry. false positive result due to pivaloylcarnitine in a newborn screening programme. J Inherit Metab Dis 21 (1998) 646-30
44. Gibson K.M., Bennett M.J., Naylor E.W., and Morton D.H. 3-methylcrotonyl-coenzyme A carboxylase deficiency in Amish/Mennonite adults identified by detection of increased acylcarnitines in blood spots of their children. J Pediatr 132 (1998) 519-523
45. Koeberl D.D., Millington D.S., Smith W.E., et al. Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening. J Inherit Metab Dis 26 (2003) 25-35
46. Wagstaff J., Korson M., Kraus J.P., and Levy H.L. Severe folate deficiency and pancytopenia in a nutritionally deprived infant with Homocystinuria caused by cystathionine beta-synthase deficiency. J Pediatr 118 (1991) 569-572
47. Smith W.E., Millington D.E., Koeberl D.K., and Lesser P.S. Glutaric aciduria Type I missed by newborn screening in an infant with dystonia following promethazine administration. Pediatrics 107 (2001) 1184-1187
48. Fearing M.F., Larson C., Strauss A., and Marsden D.L. Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty oxidation defects. J Inherit Metab Dis 28 (2005) 545-550
49. Holtzman C., Slazyk W.E., Cordero J.F., and Hannon W.H. Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism. Pediatrics 78 (1986) 553-558
50. Mudd S.H., Levy H.L., Tangerman A., Boujet C., Buist N., Davidson-Mundt A., et al. Isolated persistent hypermethioninemia. Am J Hum Genet 57 (1995) 882-892
51. Cuthbert C.D., Magera M.J., Hahn S., Tortorelli S., Rinaldo P., and Matern D. Analysis of homocysteine and methylmalonic acid in blood spots by tandem mass spectrometry as a second tier newborn screening test for homocystinuria and methylmalonic acidemias. J Inherit Metab Dis 28 suppl. 1 (2005) 8
52. Magera M.J., Gunawardena N.D., Hahn S.H., Tortorelli S., Mitchell G.A., Goodman S.I., Rinaldo P., and Matern D. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. Molec Genet Metab (2006) in press
53. Allard P., Grenier A., Korson M.S., and Zytkovicz T.H. Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry. analysis of succinylacetone extracted from dried blood spots. Clin Biochem 37 (2004) 1010-1015
54. Lacey J.M., Minutti C.Z., Magena M.J., Tauscher A.L., Casetta B., McCann M., et al. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem 50 (2004) 621-625
55. Chace D.H., Hillman S.L., Millington D.S., Kahler S.G., Roe C.R., and Naylor E.W. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clin Chem 41 (1995) 62-68
56. th National Newborn Screening Meeting; October 26-29, Portland, Oregon
57. Green N.S., and Pass K.A. Neonatal screening by DNA microarray. spots and chips. Nat Rev Genet 6 (2005) 147-151
58. Comeau A.M., Parad R.B., Dorkin H.L., Dovey M., Gerstle R., Haver K., et al. Population-based newborn screening for genetic disorders when multiple DNA testing is incorporated. a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 113 (2004) 1573-1581
59. Bhardwaj U., Zhang Y.-H., Jackson D.S., Buchanan G.R., Therrell B.L., McCabe L.L., et al. DNA diagnosis confirms hemoglobin deletion in newborn screen follow-up. J Pediatr 142 (2003) 346-348
60. Dobrowolski S.F., Baras R.A., Suzow J.G., Berkley M., and Naylor E.W. Analysis of common mutations in the galactose-1-phosphate uridyl transferase gene. J Mol Diagn 5 (2003) 42-47
61. nd-tier molecular testing in over 1.8 million specimens. Molec Genet Metab 81 (2004) 176
62. Greenberg C.R., Prasad A.N., Dilling L.A., Thompson J.R.G., Haworth J.C., Martin B., et al. Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type I in Manitoba and northwestern Ontario, Canada. Molec Genet Metab 75 (2002) 70-78
63. Lin Z., Fontaine J.M., Freer D.E., and Naylor E.W. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Molec Genet Metab 86 (2005) 212-219
64. Thomason M.J., Lord J., Bain M.D., Chalmers R.A., Littlejohns P., Addison G.M., et al. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. J Pub Hlth Med 20 (1998) 331-343
65. Venditti L.N., Venditti C.P., Berry G.T., Kaplan P.B., Kaye E.M., Glick H., et al. Newborn screening by tandem mass spectrometry for medium-chain acyl-CoA dehydrogenase deficiency. a cost-effectiveness analysis. Pediatrics 112 (2003) 1005-1015
66. Pandor A., Eastham J., Beverely C., Chilcott J., and Paisley S. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry. a systematic review. Hlth Technol Assess 8 (2004) 1-121
67. Schoen E.J., Baker J.C., Colby C.J., and To T.T. Cost-benefit analysis of universal mass spectrometry for newborn screening. Pediatrics 110 (2002) 781-786
68. Filiano J.J., Bellimer S.G., and Kunz P.L. Tandem mass spectrometry and newborn screening. pilot data and review. Pediatr Neurol 26 (2002) 201-204
69. Grosse S.D. Does newborn screening save money?. The difference between cost-effective and cost-saving interventions. J Pediatr 146 (2005) 168-170
70. Li Y., Scott C.R., Chamoles N.A., Ghavami A., Pinto B.M., Turecek F., et al. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem 50 (2004) 1785-1796
71. th ed. Edinburgh: Churchill Livingstone; in press.